Table 1.
Baseline characteristic
| Characteristic | Patients | Tumoral EHD2 expression | |||
|---|---|---|---|---|---|
|
|
|
||||
| n | % | Low | High | P-value | |
| All patients | 70 | 100 | 33 | 37 | |
| Gender | 0.976 | ||||
| Male | 55 | 78.6 | 26 | 29 | |
| Female | 15 | 21.4 | 7 | 8 | |
| Age (years) | 0.230 | ||||
| ≤55 | 32 | 45.7 | 18 | 14 | |
| >55 | 38 | 54.3 | 15 | 23 | |
| TNM stage | 0.175 | ||||
| I+II | 68 | 97.1 | 33 | 35 | |
| III+IV | 2 | 2.9 | 0 | 2 | |
| Fuhrman grade | 0.190 | ||||
| I+II | 57 | 81.4 | 29 | 28 | |
| III+IV | 13 | 18.6 | 4 | 9 | |
| Tumor size (cm) | 0.269 | ||||
| ≤4 | 39 | 55.7 | 14 | 11 | |
| >4 | 31 | 44.3 | 19 | 26 | |